Director Davis Wade purchased 5,728 shares of CHTR at $173.72 on 2026-04-28; stock has fallen 62.9% from 52-week high, amid cluster buy pattern.
Director Davis Wade purchased 5,728 shares at $173.72, increasing his holdings by 478.5% to 6,925 shares post-transaction. This acquisition occurs within a cluster pattern: 2 other insiders also bought within the past 14 days, suggesting coordinated insider accumulation at a specific price point. The stock is currently trading at $158.65, down 62.9% from its 52-week high of $427.25 and down 28.2% over the past 30 days, indicating significant recent decline. CHTR maintains a low P/E of 8.71 and $1.2B net income against $13.6B in quarterly revenue, but revenue growth is negative at -0.6% year-over-year, reflecting business headwinds that may be factored into current valuation and insider accumulation decisions.